New blood-thinner study for heart disease patients in China
Part of Heart & circulation clinical trials.
This study tests a new medication called selatogrel in people with chronic coronary syndrome (long-term heart disease caused by narrowed heart arteries). Researchers want to see how the body processes this drug and whether it helps prevent future heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with chronic coronary syndrome (narrowed heart arteries confirmed by heart catheterization or CT scan, or a previous heart attack more than 3 months ago)
- You are currently taking aspirin as your only blood-thinner medication, and have been taking it steadily for at least 1 month
- You weigh at least 110 pounds (50 kg)
- You have not had a heart attack, stent, bypass surgery, or stroke within the past 3 months
- You do not have serious liver or kidney disease, recent bleeding problems, or a hemoglobin level below 10 g/dL
- You have not taken another experimental drug in the past 3–6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way of taking blood thinners after getting a stent. Instead of staying on two blood thinners for a long time, you switch earlier to just one (ticagrelor). This might reduce bleeding risks while still protecting against heart problems.
This study compares two blood-thinning medicines, aspirin and clopidogrel, to see which is better at preventing future heart problems in people with chronic coronary artery disease. If you have had a heart attack or unstable angina at least 6 months ago, this trial may help you understand an additional option for your heart health.
This study tests an investigational medicine called HRS9531 for people with atherosclerotic cardiovascular disease (a buildup of plaque in the arteries that can lead to heart attacks and strokes). The trial aims to see if the medicine helps reduce risks in this condition.
This trial tests selatogrel to see if it can better prevent harmful heart and blood-clot outcomes after a recent heart attack. You may be considered if you had a heart attack in the past 4 weeks and have higher-risk heart artery disease.
This study tests how a new blood-thinning medication (CG-0255) works in the body and compares it with Plavix, a common blood thinner. Researchers will measure how much of the drug enters your bloodstream and what effects it has on your blood clotting ability.
This trial tests a pill that may reduce inflammation in blood vessels, which could lower the risk of heart attacks or strokes in people with atherosclerosis. It could help if you have plaque in your arteries and are at risk for major heart events.
Hear when a new Chronic Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.